Outbreak of Meningitis B

 

BACK TO MAIN INDEX

 

Meningitis B (MenB) - Patient Information Update

We are aware of recent cases of Meningococcal disease (MenB) in Kent, which have sadly resulted in the deaths of two students. We understand this news is concerning for many patients and parents.

UK Health Security Agency (UKHSA) is currently coordinating a national response. A targeted vaccination programme is being introduced, starting with students at the University of Kent, and may be expanded if required. At present, NHS services are continuing to operate as normal, and this is not a national NHS incident.

 

About meningitis and septicaemia

Meningococcal disease is a rare but serious bacterial infection that can cause meningitis (infection of the lining of the brain) and septicaemia (blood poisoning). It can become life-threatening very quickly, so early recognition and treatment are vital.

 

Symptoms to look out for include:

  • High fever
  • Severe headache
  • Vomiting
  • Drowsiness or difficulty waking
  • Cold hands and feet
  • Stiff neck
  • Sensitivity to light
  • Muscle or joint pain
  • Confusion
  • A rash that does not fade when pressed with a glass

Early symptoms can be similar to flu or a viral illness, so it is important to remain vigilant.

 

When to seek help

If you or someone you know develops these symptoms, seek urgent medical advice by contacting your GP, calling NHS 111, or dialling 999 in an emergency. Early treatment can be lifesaving.

 

MenB Vaccine

The MenB vaccine is part of the routine UK childhood immunisation schedule and is offered to infants at 8, 12, and 16 weeks, with a booster at one year of age. At present, additional (booster) vaccination is not being offered to the general population, except in specific targeted groups identified by UKHSA.

 

MenACWY Vaccine

The MenACWY vaccine protects against four strains of meningococcal bacteria (groups A, C, W and Y), which can also cause meningitis and septicaemia. In the UK, this vaccine is routinely offered to young people from around age 14, usually delivered through the school immunisation programme.

If a dose has been missed, or an individual has not previously received the vaccine, it is available free on the NHS up to the age of 25. We encourage eligible patients to ensure they are up to date with their vaccinations.

We will continue to follow national guidance and update our patients if recommendations change

 

Further information on meningococcal disease

Published: Mar 19, 2026